Cerebral phaeiohyphomycosis due to Cladophialophora bantiana.
Pardo
Fernanda
F
Ferrer
Enrique
E
Romero
Patricia Alejandra
PA
Pérez del Molino
María Luisa
ML
D000006:Abdomen, Acute / Q000209:etiology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D028226:Amyloidosis, Familial / Q000601:surgery; D000935:Antifungal Agents / Q000627:therapeutic use; D001203:Ascomycota / Q000302:isolation & purification*; D001922:Brain Abscess / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D002437:Cefazolin / Q000627:therapeutic use; D003128:Coma / Q000209:etiology; D003131:Combined Modality Therapy; D003399:Craniotomy; D004322:Drainage; D013293:Enterococcus faecalis / Q000302:isolation & purification; D017809:Fatal Outcome; D005260:Female; D005625:Frontal Lobe / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy; D012086:Reoperation; D013030:Spain / Q000453:epidemiology
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B; D002437:Cefazolin